Sun Pharma and Zydus Pharmaceuticals are recalling significant quantities of their products in the US due to manufacturing ...

Regenerative medicine is the branch of medicine that develops methods to regrow, repair or replace damaged or diseased cells, organs or tissues. Regenerative medicine includes the generation and ...

Illexcor Therapeutics is a biopharmaceutical company dedicated to the creation of next-gen oral therapies to treat patients ...

India's Zydus Lifesciences is set to acquire an 85.6% stake in France's Amplitude Surgical for nearly $280 million to expand ...

Additionally, advancements in personalized medicine and innovative treatment approaches are ... Industries Ltd., Amneal ...

Zydus Lifesciences Ltd on Wednesday (March 5) said it has received final approval from the United States Food and Drug Administration (USFDA) to market Dasatinib tablets in multiple strengths —20 mg, ...

Zydus Lifesciences announced that it has launch ANVIMO (Letermovir), a new and innovative treatment for the prevention of Cytomegalovirus (CMV) infection in hematopoietic stem cell transplant (HSCT) ...

Revlimid is a cancer drug prescription medicine, which is used to treat adults with multiple myeloma. Jefferies sees Zydus Lifesciences as long-term investment Jefferies has a Buy rating on the ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Personalized medicine is a therapeutic approach involving the use of an individual’s genetic and epigenetic information to tailor drug therapy or preventive care. We developed an endothelial ...